Selected article for: "dependent manner and flow rate"

Author: Attaway, Amy H.; Faress, Jihane; Jacono, Frank; Dasarathy, Srinivasan
Title: Acute Responses to Oxygen Delivery via High Flow Nasal Cannula in Patients with Severe Chronic Obstructive Pulmonary Disease—HFNC and Severe COPD
  • Cord-id: irqqvuq1
  • Document date: 2021_4_21
  • ID: irqqvuq1
    Snippet: Differences in oxygen delivery methods to treat hypoxemia have the potential to worsen CO(2) retention in chronic obstructive lung disease (COPD). Oxygen administration using high flow nasal cannula (HFNC) has multiple physiological benefits in treating respiratory failure including reductions in PaCO(2) in a flow-dependent manner. We hypothesized that patients with COPD would develop worsening hypercapnia if oxygen fraction was increased without increasing flow rate. We evaluated the acute resp
    Document: Differences in oxygen delivery methods to treat hypoxemia have the potential to worsen CO(2) retention in chronic obstructive lung disease (COPD). Oxygen administration using high flow nasal cannula (HFNC) has multiple physiological benefits in treating respiratory failure including reductions in PaCO(2) in a flow-dependent manner. We hypothesized that patients with COPD would develop worsening hypercapnia if oxygen fraction was increased without increasing flow rate. We evaluated the acute response to HFNC in subjects with severe COPD when flow remained constant and inspired oxygen was increased. In total, 11 subjects with severe COPD (FEV1 < 50%) on supplemental oxygen with baseline normocapnia (PaCO(2) < 45 mm Hg; n = 5) and hypercapnia (PaCO(2) ≥ 45 mm Hg; n = 6) were studied. Arterial blood gas responses were studied at three timepoints: Baseline, HFNC at a flow rate of 30 L/min at resting oxygen supplementation for 1 h, and FiO(2) 30% above baseline with the same flow rate for the next hour. The primary endpoint was the change in PaCO(2) from baseline. No significant changes in PaCO(2) were noted in response to HFNC applied at baseline FiO(2) in the normocapnic and hypercapnic group. At HFNC with FiO(2) 30% above baseline, the normocapnic group did not show a change in PaCO(2) (baseline: 38.9 ± 1.8 mm Hg; HFNC at higher FiO(2): 38.8 ± 3.1 mm Hg; p = 0.93), but the hypercapnic group demonstrated significant increase in PaCO(2) (baseline: 58.2 ± 9.3 mm Hg; HFNC at higher FiO(2): 63.3 ± 10.9 mm Hg; p = 0.025). We observed worsening hypercapnia in severe COPD patients and baseline hypercapnia who received increased oxygen fraction when flow remained constant. These data show the need for careful titration of oxygen therapy in COPD patients, particularly those with baseline hypercapnia when flow rate is unchanged.

    Search related documents:
    Co phrase search for related documents
    • acute hypoxemic respiratory failure and long term acute: 1, 2
    • acute respiratory failure and adaptive response: 1, 2, 3, 4
    • acute respiratory failure and adjunctive therapy: 1, 2, 3, 4
    • acute respiratory failure and long period: 1
    • acute respiratory failure and long term acute: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute response and adaptive response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute response and adjunctive therapy: 1
    • acute response and long period: 1
    • acute response and long term acute: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute setting and adjunctive therapy: 1
    • acute setting and long period: 1
    • acute setting and long term acute: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • adaptive response and long period: 1